Diversified Trust Co Increases Stock Holdings in Stryker Corporation $SYK

Diversified Trust Co increased its position in shares of Stryker Corporation (NYSE:SYK) by 45.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,445 shares of the medical technology company’s stock after purchasing an additional 3,899 shares during the period. Diversified Trust Co’s holdings in Stryker were worth $4,601,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Brighton Jones LLC lifted its holdings in Stryker by 15.4% in the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock valued at $1,643,000 after acquiring an additional 609 shares during the last quarter. State of Wyoming purchased a new stake in Stryker in the first quarter valued at $62,000. Quarry LP lifted its stake in shares of Stryker by 83.3% in the 1st quarter. Quarry LP now owns 187 shares of the medical technology company’s stock valued at $70,000 after purchasing an additional 85 shares during the last quarter. 1248 Management LLC purchased a new position in shares of Stryker during the 1st quarter worth $152,000. Finally, EP Wealth Advisors LLC increased its position in shares of Stryker by 0.9% during the 1st quarter. EP Wealth Advisors LLC now owns 194,858 shares of the medical technology company’s stock worth $72,536,000 after purchasing an additional 1,716 shares during the last quarter. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Stryker news, CAO William E. Berry, Jr. sold 1,953 shares of the stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $365.49, for a total value of $713,801.97. Following the sale, the chief accounting officer directly owned 2,833 shares of the company’s stock, valued at approximately $1,035,433.17. This represents a 40.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Ronda E. Stryker sold 276,173 shares of the firm’s stock in a transaction on Thursday, November 6th. The shares were sold at an average price of $353.28, for a total transaction of $97,566,397.44. Following the completion of the sale, the director owned 2,702,108 shares in the company, valued at $954,600,714.24. The trade was a 9.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 522,118 shares of company stock worth $185,381,932 in the last 90 days. Corporate insiders own 5.20% of the company’s stock.

Analyst Ratings Changes

SYK has been the topic of a number of recent analyst reports. Wall Street Zen raised shares of Stryker from a “hold” rating to a “buy” rating in a research report on Sunday, December 21st. Rothschild Redb upgraded shares of Stryker to a “hold” rating in a report on Thursday, September 18th. Redburn Partners set a $420.00 target price on Stryker in a research report on Thursday, September 18th. Barclays upped their price target on Stryker from $443.00 to $453.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Finally, Citigroup cut their price objective on Stryker from $455.00 to $420.00 and set a “buy” rating on the stock in a report on Thursday, December 11th. Thirteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $431.84.

Stryker Stock Down 0.5%

Shares of NYSE SYK opened at $352.31 on Tuesday. The stock has a market cap of $134.73 billion, a P/E ratio of 46.30, a PEG ratio of 2.51 and a beta of 0.89. The business’s fifty day simple moving average is $363.20 and its 200-day simple moving average is $376.26. Stryker Corporation has a 12-month low of $329.16 and a 12-month high of $406.19. The company has a current ratio of 1.85, a quick ratio of 1.13 and a debt-to-equity ratio of 0.68.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Friday, October 31st. The medical technology company reported $3.19 earnings per share for the quarter, topping the consensus estimate of $3.13 by $0.06. The company had revenue of $6.06 billion for the quarter, compared to the consensus estimate of $6.04 billion. Stryker had a return on equity of 24.07% and a net margin of 12.07%.Stryker’s revenue was up 10.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.87 EPS. As a group, equities analysts predict that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be paid a $0.88 dividend. This is an increase from Stryker’s previous quarterly dividend of $0.84. This represents a $3.52 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Wednesday, December 31st. Stryker’s payout ratio is presently 44.15%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.